BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Vrije Universiteit Amsterdam//NONSGML v1.0//EN
NAME:PhD defence W.G. ter Meulen
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART:20260112T114500
DTEND:20260112T131500
DTSTAMP:20260112T114500
UID:phd-defence-w-g-ter-meulen@8F96275E-9F55-4B3F-A143-836282E12573
CREATED:20260826T004113
LOCATION:
SUMMARY:PhD defence W.G. ter Meulen
X-ALT-DESC;FMTTYPE=text/html: <html> <body> <p><p>Comorbidity of mood 
 disorders and substance use disorders: in concert and co-travelling</
 p></p> <h3>Depression and smoking prove a persistent combination: res
 earch shows why integrated care is urgently needed</h3><p>Psychiatric
  disorders often occur together. This phenomenon - comorbidity - is n
 ot only common but also remarkably persistent: people who develop mul
 tiple problems at the same time tend to keep them for long periods. R
 esearch by psychiatrist Wendela ter Meulen sheds light on why this ha
 ppens and what the societal consequences are.</p><p><strong>More symp
 toms, more risk</strong>s<br>A synthesis of existing studies on the m
 ost common combination - depression and anxiety - shows that people w
 ho experience both conditions suffer from more severe psychological s
 ymptoms and face a higher risk of physical health problems, social li
 mitations, and reduced quality of life. Psychosocial factors, such as
  childhood trauma, play a significant role in the development of this
  double burden.</p><p><strong>People with depression smoke the most</
 strong><br>In a follow-up study, Ter Meulen compared risk factors for
  smoking among people with and without depression. The differences we
 re striking: people with depression not only smoke far more often, bu
 t they also encounter circumstances - such as financial hardship or s
 tressful living conditions - that reinforce smoking behaviour. This m
 akes quitting substantially more difficult.</p><p><strong>Disease pro
 gression as the silent driver of comorbidity</strong><br>Ter Meulen a
 lso examined the long-term course of mood disorders. Some people reco
 ver less well from depression or experience more episodes of bipolar 
 mood instability. This so-called disease progression appears to be th
 e main driver behind the persistent pairing of mood disorders and sub
 stance-use problems. In addition, a clinical assessment tool that mea
 sures comorbidity seems reasonably able to predict which people with 
 depression later develop bipolar disorder.</p><p><strong>Impact and o
 pportunities for healthcare</strong><br>The findings make clear that 
 comorbidity leads to a stacking of risks and adverse outcomes - psych
 ological, physical, and social. This underscores the need for integra
 ted care, in which conditions are not treated separately but addresse
 d together within a single care pathway. A lesser-known but socially 
 relevant insight is that early in the course of bipolar disorder, a v
 ulnerable period may exist in which substance use is especially desta
 bilising. According to the researchers, education and prevention coul
 d yield significant benefits here.</p><p>Smokers with depression also
  deserve special attention: they often succeed in reducing their smok
 ing only after their depressive symptoms improve - sometimes even par
 tially is enough. This calls for treatment approaches that tackle dep
 ression and addiction simultaneously, such as combined psychotherapy.
  Ter Meulen’s work shows that better, integrated care not only help
 s individual patients but may also reduce health problems, lower drop
 out from work or education, and ultimately decrease societal costs.</
 p><p>More information on the <a href="https://hdl.handle.net/1871.1/8
 4472c4c-2a26-4d02-b201-91017e61be65" data-new-window="true" target="_
 blank" rel="noopener noreferrer">thesis</a></p> </body> </html>
DESCRIPTION: Comorbidity of mood disorders and substance use disorders
 : in concert and co-travelling <h3>Depression and smoking prove a per
 sistent combination: research shows why integrated care is urgently n
 eeded</h3>Psychiatric disorders often occur together. This phenomenon
  - comorbidity - is not only common but also remarkably persistent: p
 eople who develop multiple problems at the same time tend to keep the
 m for long periods. Research by psychiatrist Wendela ter Meulen sheds
  light on why this happens and what the societal consequences are.<st
 rong>More symptoms, more risk</strong>s<br>A synthesis of existing st
 udies on the most common combination - depression and anxiety - shows
  that people who experience both conditions suffer from more severe p
 sychological symptoms and face a higher risk of physical health probl
 ems, social limitations, and reduced quality of life. Psychosocial fa
 ctors, such as childhood trauma, play a significant role in the devel
 opment of this double burden.<strong>People with depression smoke the
  most</strong><br>In a follow-up study, Ter Meulen compared risk fact
 ors for smoking among people with and without depression. The differe
 nces were striking: people with depression not only smoke far more of
 ten, but they also encounter circumstances - such as financial hardsh
 ip or stressful living conditions - that reinforce smoking behaviour.
  This makes quitting substantially more difficult.<strong>Disease pro
 gression as the silent driver of comorbidity</strong><br>Ter Meulen a
 lso examined the long-term course of mood disorders. Some people reco
 ver less well from depression or experience more episodes of bipolar 
 mood instability. This so-called disease progression appears to be th
 e main driver behind the persistent pairing of mood disorders and sub
 stance-use problems. In addition, a clinical assessment tool that mea
 sures comorbidity seems reasonably able to predict which people with 
 depression later develop bipolar disorder.<strong>Impact and opportun
 ities for healthcare</strong><br>The findings make clear that comorbi
 dity leads to a stacking of risks and adverse outcomes - psychologica
 l, physical, and social. This underscores the need for integrated car
 e, in which conditions are not treated separately but addressed toget
 her within a single care pathway. A lesser-known but socially relevan
 t insight is that early in the course of bipolar disorder, a vulnerab
 le period may exist in which substance use is especially destabilisin
 g. According to the researchers, education and prevention could yield
  significant benefits here.Smokers with depression also deserve speci
 al attention: they often succeed in reducing their smoking only after
  their depressive symptoms improve - sometimes even partially is enou
 gh. This calls for treatment approaches that tackle depression and ad
 diction simultaneously, such as combined psychotherapy. Ter Meulen’
 s work shows that better, integrated care not only helps individual p
 atients but may also reduce health problems, lower dropout from work 
 or education, and ultimately decrease societal costs.More information
  on the <a href="https://hdl.handle.net/1871.1/84472c4c-2a26-4d02-b20
 1-91017e61be65" data-new-window="true" target="_blank" rel="noopener 
 noreferrer">thesis</a>
END:VEVENT
END:VCALENDAR
